Skip to main content
. 2020 Nov 10;10(1):70–78. doi: 10.1002/cam4.3568

FIGURE 4.

FIGURE 4

Hazards of new‐onset symptoms in carfilzomib users as compared to nonusers. CI, confidence interval; HR, hazards ratio